Summary: RayStation Version 1 0 is a treatment planning system used in radiotherapy. It is primarily used for dose calculation and optimization in various radiotherapy modalities. Key evidence includes validation of its Monte Carlo dose engine for proton therapy.
RayStation Version 1 0 was cleared by the FDA through the 510(k) pathway on March 12, 2010. It is manufactured by Raysearch Laboratories Ab and classified as a Class 2 device.
What It Is
RayStation Version 1 0 is a treatment planning system designed to assist clinicians in planning radiotherapy treatments. It provides tools for dose calculation, optimization, and evaluation, enhancing the precision of radiotherapy delivery.
Clinical Applications
Commonly used in radiotherapy centers, RayStation Version 1 0 is applied in planning treatments for various cancers, including those requiring complex dose distributions such as proton therapy and very high-energy electron beams.
Evidence Summary
The available literature includes four studies, ranging from 2016 to 2026, focusing on dose calculation and quality assurance in radiotherapy. These studies include validation and comparison of treatment planning methodologies.
Reported Outcomes
Published studies report successful validation of RayStation's Monte Carlo dose engine for proton therapy, ensuring accurate dose calculations. Additionally, the system's capability in planning very high-energy electron beams has been demonstrated, showing comparable efficacy to volumetric modulated arc therapy.
Safety Profile
Reported complications include potential discrepancies in dose calculation under certain conditions, as highlighted in quality assurance studies. However, no significant adverse events were directly attributed to the use of RayStation Version 1 0 in the reviewed literature.
Evidence Limitations
The evidence is limited by the small number of studies and the lack of large-scale clinical trials. Further research is needed to explore long-term outcomes and safety in diverse clinical settings.
Frequently Asked Questions
What are the clinical indications for RayStation Version 1 0?
RayStation Version 1 0 is indicated for use in planning radiotherapy treatments, particularly in scenarios requiring precise dose calculations such as proton therapy and high-energy electron beam therapy.
What outcomes have been reported in clinical studies?
Clinical studies have reported successful validation of the Monte Carlo dose engine for proton therapy and effective planning capabilities for very high-energy electron beams.
What complications have been reported?
Reported complications include potential discrepancies in dose calculation, as noted in quality assurance studies, but no significant adverse events were directly linked to the device.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.
📬 Stay Updated
Get the latest vascular education content delivered to your inbox.